Join enGene Therapeutics for a virtual market-focused discussion featuring Neal Shore, MD, FACS (Carolina Urologic Research Center; Atlantic Urology Clinics), who will join management to provide insights into the evolving NMIBC treatment landscape and the various considerations driving treatment selection.

The event will provide an overview of:

• The future treatment paradigm in NMIBC and how sequencing therapies may evolve
• Insights on community urology practices and how treatment considerations and choice drivers vary
• Pricing and reimbursement dynamics

A live question and answer session will follow the formal presentations.